Basic information
Biomarker: CD10
Histology type: endometrial stromal tumor
Cohort characteristics
Country: Northern Ireland
Region: Belfast
Followed up time :
Subgroup 1 name : positive in normal control
Subgroup 1 number: 0
Subgroup 2 name: nagtive in normal control
Subgroup 2 number: 13
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
67 | endometrial stromal neoplasms | 54 | normal endometrial stroma | 13 |
Sample information
Conclusion: CD10 is a reliable and sensitive immunohistochemical marker of normal endometrial stroma. Positivity, which is often strong and/or diffuse is found in endometrial stromal nodules and low-grade ESS. Positive staining with CD10, when strong and diffuse, may be useful in distinguishing these tumours from histological mimics, especially cellular leiomyoma and AGCT which are generally negative. In this situation, CD10 should be used as part of a panel which might include desmin and a-inhibin depending on the differential diagnosis considered. Positive staining with CD10 in a high-grade uterine sarcoma which is negative with muscle markers might indicate endometrial stromal differentiation and identify a group of neoplasms which it is correct to diagnose as high-grade ESS rather than undifferentiated uterine sarcoma.
Sample type : tissue
Sample method: immunohistochemistry
Expression elevation: Positive staining was subjectively classied as weak, moderate or strong. Staining was further classied as focal or diffuse (arbitrarily taken as involving >50% of the tumour).
Disease information
Related information
Funtion Uniprot: Thermolysin-like specificity, but is almost confined on acting on polypeptides of up to 30 amino acids (PubMed:6349683, PubMed:6208535, PubMed:15283675, PubMed:8168535). Biologically important in the destruction of opioid peptides such as Met- and Leu-enkephalins by cleavage of a Gly-Phe bond (PubMed:6349683, PubMed:17101991). Catalyzes cleavage of bradykinin, substance P and neurotensin peptides (PubMed:6208535). Able to cleave angiotensin-1, angiotensin-2 and angiotensin 1-9 (PubMed:6349683, PubMed:15283675). Involved in the degradation of atrial natriuretic factor (ANF) and brain natriuretic factor (BNP(1-32)) (PubMed:2531377, PubMed:2972276, PubMed:16254193). Displays UV-inducible elastase activity toward skin preelastic and elastic fibers (PubMed:20876573).
UniProt ID: P08473
UniProt Link: https://www.uniprot.org/uniprotkb/P08473/entry
Molecular function from UniProt:
Subcellular UniProt: #Cell membrane #Membrane
Alternative name from UniProt:
Miscellaneous: Important cell surface marker in the diagnostic of human acute lymphocytic leukemia
Catalytic activity: Preferential cleavage of polypeptides between hydrophobic residues, particularly with Phe or Tyr at P1'.H2O + substance P = L-Leu-L-Met-NH2 + substance P(1-9)This reaction proceeds in the forward direction.;H2O + substance P = L-Phe-Gly-L-Leu-L-Met-NH2 + substance P(1-7) This reaction proceeds in the forward direction;H2O + neurotensin = L-isoleucyl-L-leucine + neurotensin(1-11) This reaction proceeds in the forward direction.;H2O + neurotensin = L-tyrosyl-L-isoleucyl-L-leucine + neurotensin(1-10) This reaction proceeds in the forward direction.;
Activity regulation: Inhibited in a dose dependent manner by opiorphin (PubMed:17101991). Activated by K49-P1-20, a twenty-residue synthetic peptide shortened from the snake B.asper myotoxin II (PubMed:26931059).
Recommended name: Neprilysin
Gene name from HGNC: MME (CALLA, CD10, NEP)
CD antigen name: CD10
HPA class: Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Human disease related genes Plasma proteins
AlphaFold DB: P08473
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P08473
HPA link: https://www.proteinatlas.org/ENSG00000196549-MME
Tissue specificity RNA from HPA: Tissue enhanced (intestine, kidney)
Tissue expression from HPA: Distinct luminal membrane expression in the small intestine, kidney, epididymis and prostate. Membranous expression in hepatocytes.
Single cell type specificity Cell type enhanced (Proximal enterocytes, Endometrial stromal cells, Syncytiotrophoblasts, Proximal tubular cells)
Immune cell specificity: Immune cell enriched (neutrophil)
Cancer prognostic summary HPA Group enriched (basal ganglia, medulla oblongata, pons, thalamus)
Pathology link: https://www.proteinatlas.org/ENSG00000196549-MME/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000196549-MME/pathology/endometrial+cancer
Phenotype ID: 617017;617018;
Disease: Charcot-Marie-Tooth disease 2T (CMT2T);Spinocerebellar ataxia 43 (SCA43);
Note1: The disease is caused by variants affecting the gene represented in this entry;The disease is caused by variants affecting the gene represented in this entry;
OMIM: 120520;617017;617018;
OMIM link1: https://www.omim.org/entry/617017;https://www.omim.org/entry/617018;
OMIM link2: https://www.omim.org/entry/120520;https://www.omim.org/entry/617017;https://www.omim.org/entry/617018
HGNC ID: HGNC:7154
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:7154